Stemtech (STEK) EBIT (2012 - 2025)

Stemtech has disclosed EBIT across 14 years of filings, most recently posting $994644.0 for Q4 2025.

• EBIT for Q4 2025 came in at $994644.0, down 38.88% year-over-year; the trailing twelve-month figure through Dec 2025 was -$850466.0 (down 7.35% YoY), and the FY2025 annual result was -$850466.0, down 7.35% from the prior year.
• EBIT came in at $994644.0 for Q4 2025 at Stemtech, up from -$339217.0 in the prior quarter.
• In the past five years, EBIT ranged from a high of $2.8 million in Q4 2022 to a low of -$3.4 million in Q3 2022.
• The 5-year median for EBIT is -$578603.5 (2021), against an average of -$303479.8.
• Across the five-year window, EBIT soared 2783.73% in 2022 and tumbled 593.0% in 2023, its largest moves.
• Stemtech's EBIT stood at -$104270.0 in 2021, then jumped by 2783.73% to $2.8 million in 2022, then tumbled by 40.79% to $1.7 million in 2023, then declined by 1.78% to $1.6 million in 2024, then sank by 38.88% to $994644.0 in 2025.
• The last three EBIT figures came in at $994644.0 (Q4 2025), -$339217.0 (Q3 2025), and -$300988.0 (Q2 2025), per Business Quant data.